Jazz Pharmaceuticals to Present Extensive New Data and Real-World Evidence Highlighting Epidiolex® (cannabidiol) Outcomes in Treatment-Resistant Epilepsies at the American ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that eight abstracts, including four that are late-breaking, will be presented on Epidiolex® (cannabidiol) at the American Epilepsy Society (AES ...
Multiple Sclerosis News Today

Oral bacteria tied to more severe multiple sclerosis symptoms

Researchers report that elevated levels of the oral bacteria Fusobacterium nucleatum may be linked with greater disability in ...
The Lancet

Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications

eMultiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, ...
The New York Times

The Young Women Grappling With an ‘Old Man’s Disease’

Diagnosed with A.L.S., they traded stories, drank tequila and made grim jokes at a unique annual gathering on Cape Cod. Laura McNew-Isaacs had makeup done in advance of a dinner and drag show at the ...
Frontiers

Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis

Background: The kappa free light chain (κ-FLC) index is a well-established biomarker in multiple sclerosis (MS). While the prognostic value of the κ-FLC index has been demonstrated in early ...